Aug. 14 at 2:18 PM
Noble Capital Markets Research Report: The Oncology Institute, Inc. (
$TOI) – Patient Additions And Pharmacy Division Drive 2Q25 Revenues Above Expectations
Revenues Were Driven By New Patients Under Contract. The Oncology Institute reported a loss for 2Q25 of
$17.0 million or $(0.15) per share. Revenues of
$119.8 million exceeded our estimate of
$110.4 million. The company discussed newly active or pending contracts that will add covered lives during 2H25. It reiterated its guidance for Revenues, Gross Profit, Adjusted EBITDA, and Free Cash Flow. Cash on June 30, 2025 was
$30.3 million.
Read more: https://www.channelchek.com/news-channel/the-oncology-institute-inc-toi-patient-additions-and-pharmacy-division-drive-2q25-revenues-above-expectations
